Melatonin in Patients With Multiple Sclerosis (MS).

Clinical trial NCT03498131 · COMPLETED

Trial details

NCT number: NCT03498131
Sponsor: Providence Health & Services
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2018-05-09
Primary completion: 2022-07-29
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.